4536:TYO
Santen Pharmaceutical Co Ltd
Â¥1,743.00
arrow_upward
+1.04%(+18.00) 1D
Set 14, 3:30:00 PM GMT+9 · JPY
search
Lahat ng simbolo
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Simbolo | Presyo | Palitan | % ng Pagbabago |
|---|
insights_autoBumubuo ng mga nangungunang insight para sa 4536...
Buksan
Â¥1,730
Mataas
Â¥1,751
Mababa
Â¥1,709
Mkt. cap
561.75B
Avg. na dami
1.19M
Dami
882.90K
Dividend
2.18%
Bawat tatlong buwang dividend
Â¥9
Petsa ng ex-dividend
Set 29, 2026
P/E ratio
14.55
Mataas nang 52-wk
Â¥2,254
Mababa nang 52-wk
Â¥1,458
EPS
Â¥120
Mga natitirang share
407.09M
Bilang ng mga empleyado
4K
Buksan
Â¥1,730
Mataas
Â¥1,751
Mababa
Â¥1,709
Mkt. cap
561.75B
Avg. na dami
1.19M
Dami
882.90K
Dividend
2.18%
Bawat tatlong buwang dividend
Â¥9
Petsa ng ex-dividend
Set 29, 2026
P/E ratio
14.55
Mataas nang 52-wk
Â¥2,254
Mababa nang 52-wk
Â¥1,458
EPS
Â¥120
Mga natitirang share
407.09M
Bilang ng mga empleyado
4K
Profile
Santen Pharmaceutical Co., Ltd., is a Japanese pharmaceutical company, specializing in ophthalmology. With its ophthalmic products Santen holds the top share within the Japanese market and is one of the leading ophthalmic companies worldwide, with its products being sold in over 50 countries.
The company was founded in 1890 by Kenkichi Taguchi, as Taguchi Santendo, and in 1925, Santendo Co., Ltd. was established. In 2014 Santen announced that it has entered into an agreement with Merck & Co. to purchase Merck's ophthalmology products. Wikipedia
Tungkol sa Santen Pharmaceutical Co Ltd
CEOAkira Kurokawa | Shigeo Taniuchi
Mga Empleyado3.97K
Itinatag1890
HeadquartersLungsod ng Osaka, Kansai, Japan
Sektor-
Websitesanten.com